Presenilin Variants in the Modulation of Hippocampal Neurogenesis
Principal Investigator: Sangram S Sisodia
Abstract: DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by impairments in memory and cognition, neuronal loss and deposition of beta-amyloid (Abeta) peptides that are derived from larger amyloid precursor proteins (APP). Inheritance of mutated PSEN1 and PSEN2 genes, encoding presenilin 1 and presenilin 2 (PS1 and PS2) variants, respectively, cause early-onset, autosomal dominant forms of familial AD (FAD), an aggressive form of disease that affects patients in the second to fifth decades of life (Price and Sisodia, 1998). We have demonstrated that expression of human FAD-linked PS1 variants in all CNS cell types in transgenic mice impairs environmental enrichment (EE)-induced division (termed proliferation) and production of new neurons (termed neurogenesis) of precursor cells (termed NPCs) in the hippocampus (Choi et al., 2008), and the experiments proposed in this application are designed to clarify the molecular and cellular mechanism(s) by which these mutant PS1 variants alters the homeostasis of hippocampal NPCs. Because the hippocampal NPCs provide a cellular reservoir for replacement of granule cells during normal aging, we suggest that in AD, mechanisms responsible for NPC division and neuronal differentiation are impaired and hence cannot fully compensate for the severe neuronal loss in disease. Indeed, recent studies have revealed a marked reduction in the numbers of NPC and their derivatives in brains of aged humans and patients with AD. As the hippocampus plays a central role in memory formation, understanding the physiological and molecular underpinnings of mutant PS1 on NPC proliferation and neurogenesis is critical. To this end, we have shown that proliferation and neurogenesis of hippocampal NPCs are controlled, at least in part, by microglial cells in the hippocampal niche by non-cell autonomous mechanisms. We now propose three Aims in which we will employ biochemical and genetic strategies to elucidate the cellular and molecular mechanisms underlying the effects of FAD-linked PS1 on proliferation and neuronal differentiation of adult hippocampal progenitors.
Funding Period: 2011-09-01 - 2016-06-30
more information: NIH RePORT
- Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiationSe Hoon Choi
Committee on Neurobiology, University of Chicago, Chicago, IL 60637, USA
Neuron 59:568-80. 2008....
- Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signalingKarthikeyan Veeraraghavalu
Department of Neurobiology, The University of Chicago, Chicago, Illinois 60637, USA
J Neurosci 30:6903-15. 2010..Hence, we argue that a partial reduction in PS-dependent gamma-secretase processing of the Notch, at least in part, accounts for the impairments observed in SVZ NPCs expressing the FAD-linked PS1DeltaE9 variant...
- ALZHEIMER DISEASE RESEARCH CENTERHELENA CHANG CHUI; Fiscal Year: 2013..abstract_text> ..
- Emory Alzheimer's Disease CenterAllan I Levey; Fiscal Year: 2013..abstract_text> ..
- ALZHEIMERS DISEASE RESEARCH CENTERJohn Morris; Fiscal Year: 2013..Changing tau protein levels and tau protein isoforms in mouse models of dementia;(Timothy Miller) 3. APOE metabolism in AD and controls;(Randall Bateman). ..
- Sleep/Wake Fragmentation with Age: Molecular MechanismsALLAN IAN PACK; Fiscal Year: 2013..These three projects are supported by three cores;a) Administrative Core;b) Mouse Behavioral Core;and c) Biostatistics and Bioinformatics Core. ..
- Massachusetts Alzheimer's Disease Research CenterBradley T Hyman; Fiscal Year: 2013..Going forward, the MADRC will continue to expand its clinical and neuropathological resources, its innovative training and scientific programs directed toward AD research. ..
- The Role of CX3CR1 Signaling in Alzheimer's Disease PathogenesisSungho Lee; Fiscal Year: 2013..In Specific Aim 3, Cx3cr1-deficient microglia will be examined for their capacity to phagocytose A-beta and migrate to stereotactically injected A-beta. ..
- Presenilin dysfunction in the brainRaymond J Kelleher; Fiscal Year: 2013....
- Wisconsin Alzheimer's Disease Research CenterSanjay Asthana; Fiscal Year: 2013..abstract_text> ..
- Molecular Mechanisms linking Aging, Abeta Proteotoxicity and NeurodegenerationJeffery W Kelly; Fiscal Year: 2013..abstract_text> ..
- Alzheimer's Disease Research Center at Columbia UniversityScott A Small; Fiscal Year: 2013..HIPAA compliant data organization and statistical consulting services are provided under the ADRC to the research community at Columbia and external to it. ..
- Expanding the National Health AccountsDavid M Cutler; Fiscal Year: 2013..Establishment of a set of national health accounts will allow us as a society to understand which medical interventions improve the health of the U.S. population most efficiently. ..
- Stem Cells for Brain RepairDANIEL ALAN PETERSON; Fiscal Year: 2013..This study will include both young and aged animals to address this important, clinically relevant factor. ..
- A Gene therapeutic approach to stable suppression of HIV-1 replicationMICHAEL R FARZAN; Fiscal Year: 2013..These studies will establish principles and protocols directly applicable to subsequent human clinical trials. ..
- Osteocyte Regulation of Bone/Muscle with Age Lynda F Bonewald; Fiscal Year: 2013..The results of these experiments should lead to novel therapeutics for the prevention and treatment of both osteoporosis and sarcopenia. ..
- GSK-3 is a Master Regulator of Neural Progenitor Self-RenewalWilliam D Snider; Fiscal Year: 2013..Our results may also suggest new ways to expand neural stem cells in the setting of neural transplantation ..
- The amyloid cascade in a novel mouse model of Alzheimer's diseaseCarol Anne Colton; Fiscal Year: 2013..The third aim will examine a likely mechanism of NO's action, the regulation of caspase activity. ..
- Beta-Amyloid Immunization in a Canine Model of AgingElizabeth Head; Fiscal Year: 2013..abstract_text> ..
- Expanding Excellence in Developmental Biology in OklahomaLinda F Thompson; Fiscal Year: 2013..abstract_text> ..
- APP/AB/Tau biochemistry in transgenic mice, familial and sporadic ADAlex E Roher; Fiscal Year: 2013..A more complete understanding of AD molecular phenotypes and their clinical responses will aid in the discovery and application of efficacious treatments that will prevent AD or enhance the quality of life of AD patients. ..
- Alzheimer's Disease Research CenterThomas J Montine; Fiscal Year: 2013..Montine;Project 2: Therapeutic Effects of Intra-Nasal Insulin Detemir, Dr. Suzanne Craft;Project 3: Modulation of A peptide accumulation and neuron damage in vivo with adult bone marrow transplants, Dr. C. Dirk Keene. ..
- Modifiers of Beta-Amyloid Metabolism and DepositionBruce T Lamb; Fiscal Year: 2013..2) Identify and characterize genetic loci that regulate A[unreadable] deposition. 3) Characterize genetic loci responsible for diet-induced alterations in A[unreadable] metabolism and deposition. ..